BetterLife Pharma
在场
BetterLife Pharma 是一家在股票代码 BETR (CA) 下上市的公司。
高管
查看带有其 9 名主要高管的组织结构图
BetterLife Pharma 搜索最多的简介
- Ahmad Doroudian, Chief Executive Officer and Director
- Ralph Pullen, Director
- Robert Metcalfe, Director
创建提醒
跟踪 BetterLife Pharma 的高管变动
药店
BetterLife Pharma 拥有 1,842 家竞争者，其中包括 Pfizer (美国(美洲))、Johnson & Johnson (美国(美洲)) 和 Sanofi (法国)。
Popular M&A news in 药店
- Stemtech and Seacret Direct have announced they will merge (公布2024十一月22号)..
- BeiGene将改名为BeOne Medicines。 (公布2024十一月15号).
- GlycoMimetics and Crescent Biopharma have announced they will merge (公布2024十一月15号)..
药店 行业的其他推荐联系人
消息
BetterLife Pharma 的最新新闻稿
- Promise of BetterLife’s Non-hallucinogenic LSD (BETR-001) For Treating Mood Disorders Highlighted in Medical Xpress Article - A Better Life Pharma
- https://abetterlifepharma.com/wp-content/uploads/2023/03/2023-03-22-BETR-Medical-Xpress-BETR-001.v2.pdf
- BetterLife Secures Additional Mitacs Funding in Collaboration with Carleton University Research Team for BETR-001 Preclinical Depression Studies - A Better Life Pharma
- BetterLife’s BETR-001 Demonstrates BETR-001 Anti-depressant Activity in Preclinical Models of Depression - A Better Life Pharma
- https://abetterlifepharma.com/wp-content/uploads/2022/06/2022-04-06-BETR-Anti-depressant-BETR001.pdf
- BetterLife Receives FDA Response On Its Pre-IND Application For Major Depressive Disorder (MDD) Treatment With BETR-001 - A Better Life Pharma
- Press Release: BetterLife Pharma completes C$10M acquisition of LSD derivative owner Transcend Biodyanmics LLC | Cannabis Law Report
- Betterlife Pharma Inc. (OTCMKTS: BETRF) Receives First Data Set for Its Flagships LSD-Derivative Compound In Depression Treatment
- BetterLife’s BETR-001 Demonstrates BETR-001 Anti-depressant Activity in Preclinical Models of Depression - A Better Life Pharma
- https://abetterlifepharma.com/wp-content/uploads/2022/04/2022-04-06-BETR-Anti-depressant-BETR001.pdf
- View more press releases Close
通过电子邮件
